Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,654
Closed -$524K 1674
2025
Q3
$524K Buy
35,654
+17,778
+99% +$181K 0.01% 1246
2025
Q2
$176K Buy
+17,876
New +$148K ﹤0.01% 1483
2024
Q3
Sell
-24,088
Closed -$193K 1457
2024
Q2
$193K Buy
+24,088
New +$215K 0.01% 1182

Other funds holding ETNB

Y-Intercept (HK)'s ETNB Position: Q4 2025 in Review

Y-Intercept (HK) sold out of 89bio (ETNB) in Q4 2025, closing a stake of 35,654 shares — an estimated $524K sold.

Y-Intercept (HK) first reported a position in ETNB in Q2 2024 and held it in 3 quarters. The position peaked at $524K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Y-Intercept (HK) reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 35,654 89bio shares in Q4 2025, an estimated $524K.
  • Y-Intercept (HK) first reported a position in 89bio in Q2 2024 and held it in 3 quarters.
  • Y-Intercept (HK)'s 89bio position peaked at $524K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.